World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
93
Citations
28256
World Ranking
10980
National Ranking
434

Willem F. Lems publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Willem F. Lems sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 602 publications — 72nd percentile

72% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Willem F. Lems D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Willem F. Lems sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 93 D-Index — 47th percentile

47% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Willem F. Lems is affiliated with Vrije Universiteit Amsterdam in the Netherlands and focuses on medical research with a specialization in rheumatology and related fields. Their academic output spans multiple subfields including rheumatology, orthopedics and sports medicine, surgery, oncology, and molecular biology.

Their main fields of study concentrate on medicine, particularly investigations related to rheumatology. Specific research topics include rheumatoid arthritis research and therapies, bone health and osteoporosis research, osteoarthritis treatment and mechanisms, bone and joint diseases, hip and femur fractures, and spondyloarthritis studies and treatments.

They have contributed to the scientific community through publications distributed across various journals. Frequent publication venues include:

  • Annals of the Rheumatic Diseases
  • Osteoporosis International
  • RMD Open
  • Calcified Tissue International
  • Lara D. Veeken

Notable recent papers by Willem F. Lems include:

  • "How does hip osteoarthritis differ from knee osteoarthritis?" (2021), published in Osteoarthritis and Cartilage
  • "Low dose, add-on prednisolone in patients with rheumatoid arthritis aged 65+: the pragmatic randomised, double-blind placebo-controlled GLORIA trial" (2022), published in Annals of the Rheumatic Diseases
  • "Vertebral fracture: epidemiology, impact and use of DXA vertebral fracture assessment in fracture liaison services" (2021), published in Osteoporosis International
  • "Alternative and complementary therapies in osteoarthritis and cartilage repair" (2020), published in Aging Clinical and Experimental Research
  • "A patient-level key performance indicator set to measure the effectiveness of fracture liaison services and guide quality improvement: a position paper of the IOF Capture the Fracture Working Group, National Osteoporosis Foundation and Fragility Fracture Network" (2020), published in Osteoporosis International

Frequent co-authors in their research collaborations include:

  • Maarten Boers
  • Michael T. Nurmohamed
  • M. van der Esch
  • Marike van der Leeden
  • Hennie G. Raterman

Best Publications

  • Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial.

    Y. P. M. Goekoop-Ruiterman;J. K. De Vries-Bouwstra;C. F. Allaart;D. Van Zeben

  • Development of antidrug antibodies against adalimumab and association with disease activity and treatment failure during long-term follow-up.

    Geertje M. Bartelds;Charlotte L. M. Krieckaert;Michael T. Nurmohamed;Pauline A. van Schouwenburg

  • Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritis

    Geertje M Bartelds;Carla A Wijbrandts;Michael T Nurmohamed;Steven Stapel

  • Development of antiinfliximab antibodies and relationship to clinical response in patients with rheumatoid arthritis

    Gerrit Jan Wolbink;Marijn Vis;Willem Lems;Alexandre E. Voskuyl

  • Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRÉ Investigation

    V P van Halm;M J L Peters;A E Voskuyl;M Boers

  • Does Rheumatoid Arthritis Equal Diabetes Mellitus as an Independent Risk Factor for Cardiovascular Disease? A Prospective Study

    Mike J. L. Peters;Vokko P. van Halm;Alexandre E. Voskuyl;Yvo M. Smulders

  • Republished: Value of biomarkers in osteoarthritis: current status and perspectives

    M. Lotz;Johanne Martel-Pelletier;Claus Christiansen;Maria Luisa Brandi

  • Value of biomarkers in osteoarthritis: current status and perspectives

    M. Lotz;Johanne Martel-Pelletier;Claus Christiansen;Maria Luisa Brandi

  • Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFκB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis

    M Vis;E A Havaardsholm;G Haugeberg;T Uhlig

  • Proprioception in knee osteoarthritis: a narrative review

    J. Knoop;M. P. M. Steultjens;M. van der Leeden;M. van der Esch

  • Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus.

    Irene E. M. Bultink;Willem F. Lems;Piet J. Kostense;Ben A. C. Dijkmans

  • Anti-infliximab and anti-adalimumab antibodies in relation to response to adalimumab in infliximab switchers and anti-tumour necrosis factor naive patients: a cohort study

    Geertje M Bartelds;Carla A Wijbrandts;Michael T Nurmohamed;Steven O Stapel

  • Relationship between serum trough infliximab levels, pretreatment C reactive protein levels, and clinical response to infliximab treatment in patients with rheumatoid arthritis

    G.J. Wolbink;A.E. Voskuyl;W.F. Lems;E. de Groot

  • Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis

    R.N.J. de Nijs;J.W.G. Jacobs;W.F. Lems;R.F.J. Laan

  • Joint proprioception, muscle strength, and functional ability in patients with Osteoarthritis of the knee

    M. van der Esch;M. Steultjens;J. Harlaar;D. Knol

  • The ratio of circulating osteoprotegerin to RANKL in early rheumatoid arthritis predicts later joint destruction.

    P. P. Geusens;R. B. M. Landewé;P. Garnero;D. Chen

  • Serum and urinary biochemical markers for knee and hip-osteoarthritis: a systematic review applying the consensus BIPED criteria

    W.E. van Spil;J. DeGroot;W.F. Lems;J.C.M. Oostveen

  • Safe prescribing of non-steroidal anti-inflammatory drugs in patients with osteoarthritis – an expert consensus addressing benefits as well as gastrointestinal and cardiovascular risks

    Carmelo Scarpignato;Angel Lanas;Corrado Blandizzi;Willem F Lems

  • Active involvement of alarmins S100A8 and S100A9 in the regulation of synovial activation and joint destruction during mouse and human osteoarthritis.

    Peter L. E. M. van Lent;Arjen B. Blom;Rik F. P. Schelbergen;Annet Slöetjes

  • Changes in hand and generalised bone mineral density in patients with recent-onset rheumatoid arthritis

    M Güler-Yüksel;C F Allaart;Y P M Goekoop-Ruiterman;J K de Vries-Bouwstra

Frequent Co-Authors

Maarten Boers
Maarten Boers Vrije Universiteit Amsterdam
Joost Dekker
Joost Dekker University of Amsterdam
Ben A. C. Dijkmans
Ben A. C. Dijkmans Amsterdam UMC
Michael T. Nurmohamed
Michael T. Nurmohamed University of Amsterdam
Piet Geusens
Piet Geusens Maastricht University
Jos W. R. Twisk
Jos W. R. Twisk Amsterdam UMC
Gerrit Jansen
Gerrit Jansen Amsterdam UMC
Paul Lips
Paul Lips Vrije Universiteit Amsterdam
Dirk L. Knol
Dirk L. Knol VU University Medical Center
Cyrus Cooper
Cyrus Cooper University of Southampton

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online healthcare degrees can open flexible pathways for those interested in medicine or related fields. For registered nurses aiming to specialize, online msn pmhnp programs offer a way to quickly become psychiatric-mental health nurse practitioners. This specialty is in high demand and allows you to provide critical mental health care.

Those interested in leadership roles might pursue online healthcare administration programs, which teach the management and organizational skills needed in hospitals and clinics. For those seeking an advanced degree, affordable online mha programs provide a cost-effective route to becoming a healthcare manager or executive.

Finally, if your goal is a terminal degree in nursing, consider the best online dnp programs, which prepare graduates for top clinical and leadership positions within the healthcare system.

These online programs offer flexibility, varied career outcomes, and can often be more affordable than on-campus options—making them appealing choices for future healthcare professionals.

Best Scientists Citing Willem F. Lems

Trending Scientists

Recently Published Articles